Latest

Inhaled Corticosteroids Increase Risk for Pulmonary Nontuberculous Mycobacterial Infection

Inhaled Corticosteroids Increase Risk for Pulmonary Nontuberculous Mycobacterial Infection

Patients with pulmonary nontuberculous mycobacterial infections were more likely to have used inhaled corticosteroids than patients with other airway disease.

Giving Flu Shots in Pharmacies Could Increase Vaccination Coverage

Giving Flu Shots in Pharmacies Could Increase Vaccination Coverage

There were reductions in influenza cases, deaths, and costs by adding pharmacies during influenza epidemics.

CDC: Many Pregnant Women Not Receiving Influenza Vaccinations

CDC: Many Pregnant Women Not Receiving Influenza Vaccinations

Fewer than half of women who were pregnant during peak influenza vaccination period in 2017 to 2018 were vaccinated.

Population Density, Structure Impact Length of Flu Season

Population Density, Structure Impact Length of Flu Season

Larger cities with higher base transmission potentials have more diffuse influenza epidemics.

Flu Vaccine Cuts Hospitalization Rates in Pregnant Women

Flu Vaccine Cuts Hospitalization Rates in Pregnant Women

Influenza-related hospitalizations were reduced by 40% over 6 flu seasons.

Strain Selection for Annual Influenza Vaccines Should Consider Preexisting Immunity

Strain Selection for Annual Influenza Vaccines Should Consider Preexisting Immunity

Repeated exposure to the influenza virus affects antibody quantity and quality, and strains selected for seasonal vaccines may not provide coverage sufficient for individuals frequently infected and/or vaccinated.

Antipseudomonal Monotherapy Efficacious in Pneumonia

Antipseudomonal Monotherapy Efficacious in Pneumonia

Antipseudomonal combination therapy has shown poorer efficacy than antipseudomonal monotherapy in individuals with suspected pseudomonal pneumonia.

Statins Increase Risk for Medically Attended Acute Respiratory Illness

Statins Increase Risk for Medically Attended Acute Respiratory Illness

Elderly patients who have been inoculated with the influenza vaccine and who also use a statin are at a greater risk for medically attended acute respiratory illness.

Pneumococcal H Influenzae Protein D Conjugate Vaccine Effective in Children

Pneumococcal H Influenzae Protein D Conjugate Vaccine Effective in Children

The burden of childhood and infant pneumonia can be effectively reduced through the use of the pneumococcal Haemophilus influenzae protein D conjugate vaccine.

PCV13 in Young Adults With Diabetes Could Avert Pneumonia Hospitalizations

PCV13 in Young Adults With Diabetes Could Avert Pneumonia Hospitalizations

PCV13 in adults age <65 years with diabetes could reduce a substantial number of pneumonia hospitalizations.

Novel Intranasal Influenza Vaccine Shows Tolerability, Safety, and High Immune Response

Novel Intranasal Influenza Vaccine Shows Tolerability, Safety, and High Immune Response

NasoVAX, an adenovirus-based intranasal flu vaccine, shows tolerability, safety, and higher cellular immune response compared to an injectable vaccine.

Baloxavir Marboxil Safe and Effective for High-Risk Influenza

Baloxavir Marboxil Safe and Effective for High-Risk Influenza

When compared to placebo, baloxavir marboxil was associated with reduced risk of influenza complications and faster recovery.

Respiratory Tract Infection Telemedicine Visits Shorter When Antibiotics Prescribed

Respiratory Tract Infection Telemedicine Visits Shorter When Antibiotics Prescribed

Findings may highlight physician difficulty explaining to patients why antibiotics are not required.

Antibiotic Stewardship May Aid Stepdown Therapies for Community-Acquired Pneumonia

Antibiotic Stewardship May Aid Stepdown Therapies for Community-Acquired Pneumonia

The use of fluoroquinolones in stable patients with community-acquired pneumonia can be reduced with stewardship programs that share antibiotic use data and provide guidance for step-down therapy.

Omadacycline Approved for Community-Acquired Bacterial Pneumonia

Omadacycline Approved for Community-Acquired Bacterial Pneumonia

The FDA has approved Nuzyra for the treatment of adult patients with CABP and acute bacterial skin and skin structure infections.

Fluoroquinolones May Aid in Reducing Mortality in Community-Acquired Pneumonia

Fluoroquinolones May Aid in Reducing Mortality in Community-Acquired Pneumonia

For patients with CAP, antibiotic regimens including a fluoroquinolone may reduce mortality risk by 1-2% compared to beta-lactams and cephalosporins alone.

Early Oseltamivir Use Linked to Clinical Benefits in Influenza Complicating ARDS

Early Oseltamivir Use Linked to Clinical Benefits in Influenza Complicating ARDS

Patients with acute respiratory distress syndrome and confirmed influenza diagnosis treated ≤6 hours with oseltamivir had reduced length of hospital stay and a lower rate of mortality.

Variations in Influenza Vaccination Coverage Among Healthcare Employees Reported

Variations in Influenza Vaccination Coverage Among Healthcare Employees Reported

Wide variations in influenza vaccine coverage have been noted across healthcare personnel based on occupation and worksite.

Risk Factors for Multidrug-Resistant Pathogens in Pneumonia

Risk Factors for Multidrug-Resistant Pathogens in Pneumonia

Previous antibiotic use and mechanical invasive ventilation were risk factors for multidrug-resistant pathogens in hospital-associated or ventilator-associated pneumonia.

Sign Up for Free e-newsletters